Antibody

2개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleAmgenPhase 2

Blinatumomab (BLINCYTO, BLINCYTO (Blinatumomab))

Mixed Phenotype Acute Leukemia (MPAL); Measurable Residual Disease (MRD) · Mixed Phenotype Acute Leukemia (MPAL)

#MixedPhenotypeAcuteLeukemiaMPAL#Antibody#Phase2#monoclonal-antibody#MeasurableResidualDiseaseMRD+1
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 1

Pivekimab Sunirine (Pivekimab Sunirine)

Acute Myeloid Leukemia; Mixed Phenotype Acute Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#Antibody#Phase1#monoclonal-antibody#MixedPhenotypeAcuteLeukemia+1
Trials 1Status Recruiting